15 results
Thumbnail

- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells

Thumbnail

- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study

Thumbnail

- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib

Thumbnail

- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series

Thumbnail

- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis

Thumbnail

D2.545 - Perception of adult patients in an allergy clinic after using Scribe artificial intelligence, our experience

Thumbnail

D2.546 - Ethical Impact of Generative AI in Clinical Practice for Asthma and Allergy

Thumbnail

D2.547 - The Transparent and Credible AI for Clinical Protocols

Thumbnail

D2.548 - Expert Evaluation of Dialogue Quality and Clinical Reasoning in a Hybrid Multilingual LLM–Algorithm Allergy Decision-Support System: A Pilot Study of 34 Real-World Cases

Thumbnail

D3.430 - The effect of biological treatment of atopic dermatitis in children

Thumbnail

D3.431 - Dupilumab therapy of patients with chronic rhinosinusitis with nasal polyps: long-term observational study

Thumbnail

D3.432 - Severe chronic rhinosinusitis - diagnostic and therapeutic challenges, personalized approach and place of biological treatment: a clinical case

Thumbnail

D3.433 - An effect on lipid profile of biologic therapy independent from weight variation

Thumbnail

D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data

Thumbnail

D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”